Khaled Mahmoud Abouelkhair

@mans.edu.eg

Associated professor clinical oncology/ Mansoura Faculty of Medicine
Mansoura university

Khaled Mahmoud Abouelkhair


                  Download Compact PDF  
https://researchid.co/abulkhair

RESEARCH, TEACHING, or OTHER INTERESTS

Oncology, Gastroenterology
7

Scopus Publications

300

Scholar Citations

7

Scholar h-index

6

Scholar i10-index

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

  • A Randomized, Double-Blind, Placebo Controlled Trial of Omeprazole as A Promising Drug for Protection Against Chemo Induced Neuropathy
    AKM Sadek AM, Hegazy SK, Hamada ZM
    Int J Drug Deliv Technol 16 (1s), 862-873 , 2026
    2026
  • Impact of consolidation chemotherapy after concurrent chemoradiation in locally advanced cervical cancer—a randomized controlled trial
    H Elghamery, GE Eladawei, H Wahba, R Hemida, KM Abouelkhair
    Oncology in Clinical Practice 22 , 2026
    2026
  • Association of PD-L1 expression with adverse pathological features in adult diffuse astrocytoma
    RK Elsaid, MM Abuhashim, SA Ashamallah, KM Abouelkhair, MM Zaki
    Egyptian Journal of Basic and Applied Sciences 12 (1), 526-541 , 2025
    2025
  • 633ep- Palbociclib + ET in Premenopausal women versus Combined Chemotherapy with HR+/Her2- Breast Cancer with Visceral Metastases
    MD Abdallah Ahmad Khalil, Khaled Abouelkhair, Mona Foda
    ESMO breast , 2025
    2025
  • Palbociclib plus endocrine therapy in Premenopausal women in HR+/Her2-Breast Cancer with Visceral Metastases versus Combined Chemotherapy
    MD Abdallah Ahmad Khalil, Khaled Abouelkhair, Mona Foda
    Journal of Carcinogenesis 24 (3), 635-642 , 2025
    2025
  • 190P The role of liver biopsy for unsettled HCC diagnosis: A single-center experience
    A El Sergany, W Elkashef, O Abdallah, O Elmetwally, RA Zayed, F Sabry, ...
    Annals of Oncology 35, S86 , 2024
    2024
    Citations: 1
  • Treatment Outcome and Prognostic factors of Glioblastoma Multiforme
    AMF Ahmed EMA, Abdalla EA, Abouelkhair KM
    SECI Oncology 4, 344-352 , 2024
    2024
  • MDCT evaluation of hepatic manifestations in Malignant hematological disorders
    A El-Badrawy, A Tawfik, G Saleh, M Abdel-Naby, H Ghazy, Z Emarah, ...
    CARDIOVASCULAR DISORDER AND MEDICINE Учредители: Science Repository OU, 1-6 , 2020
    2020
    Citations: 1
  • Science Repository
    A El-Badrawy, A Tawfik, G Saleh, M Abdel-Naby, H Ghazy, Z Emarah, ...
    2020
  • The additive role of 1H-magnetic resonance spectroscopic imaging to ensure pathological complete response after neoadjuvant chemotherapy in breast cancer patients
    D Bayoumi, M Zaky, D Ibrahim, A Abdallah, K Abouelkhair
    Polish journal of radiology 84, 570-580 , 2019
    2019
    Citations: 7
  • Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab
    R Giampieri, A Mandolesi, KM Abouelkhair, C Loretelli, M Del Prete, ...
    Journal of translational medicine 13 (1), 140 , 2015
    2015
    Citations: 8
  • Molecular selection for colorectal cancer (CRC) patients receiving cetuximab: Final results of a prospective study.
    M Scartozzi, R Giampieri, M Del Prete, A Mandolesi, L Faloppi, ...
    Journal of Clinical Oncology 33 (3_suppl), 596-596 , 2015
    2015
  • Sunitinib adverse events in metastatic renal cell carcinoma: a meta-analysis
    EM Ibrahim, GA Kazkaz, KM Abouelkhair, AM Bayer, OA Elmasri
    International journal of clinical oncology 18 (6), 1060-1069 , 2013
    2013
    Citations: 48
  • Evaluation of the inferior pedicle therapeutic mammoplasty as a primary procedure for upper quadrant breast cancer
    A Denewer, W Elsoudi, O Hussein, A Khater, W El-sadda, K Abouelkher
    EUROPEAN JOURNAL OF CANCER 49, S464-S464 , 2013
    2013
  • Molecular biomarkers for a prognostic stratification of K-RAS wild type colorectal cancer patients receiving irinotecan-cetuximab: Preliminary results of a prospective study
    M Scartozzi, R Giampieri, A Mandolesi, KM Abouelkhair, C Loretelli, ...
    EUROPEAN JOURNAL OF CANCER 49, S562-S562 , 2013
    2013
  • Prognostic stratification of k-RAS wild type colorectal cancer patients receiving irinotecan-cetuximab treatment: Preliminary results of a prospective study.
    M Scartozzi, R Giampieri, A Mandolesi, KM Abouelkhair, C Loretelli, ...
    Journal of Clinical Oncology 31 (15_suppl), 3591-3591 , 2013
    2013
  • Increased risk of second lung cancer in Hodgkin’s lymphoma survivors: a meta-analysis
    EM Ibrahim, GA Kazkaz, KM Abouelkhair, MM Al-Mansour, TM Al-Fayea, ...
    Lung 191 (1), 117-134 , 2013
    2013
    Citations: 58
  • Evaluation of inferior pedicle therapeutic mammoplasty as a primary procedure for upper quadrants early breast cancer
    A Denewer, W Elnahas, O Hussein, A Khater, W El-Sadda, K Abouelkher
    Adv Breast Cancer Res 2 (3), 86-90 , 2013
    2013
    Citations: 12
  • Risk of second breast cancer in female Hodgkin’s lymphoma survivors: a meta-analysis
    EM Ibrahim, KM Abouelkhair, GA Kazkaz, OA Elmasri, M Al-Foheidi
    BMC cancer 12 (1), 197 , 2012
    2012
    Citations: 97
  • Clinical outcome of panitumumab for metastatic colorectal cancer with wild-type KRAS status: a meta-analysis of randomized clinical trials
    EM Ibrahim, KM Abouelkhair
    Medical Oncology 28 (Suppl 1), 310-317 , 2011
    2011
    Citations: 23

MOST CITED SCHOLAR PUBLICATIONS

  • Risk of second breast cancer in female Hodgkin’s lymphoma survivors: a meta-analysis
    EM Ibrahim, KM Abouelkhair, GA Kazkaz, OA Elmasri, M Al-Foheidi
    BMC cancer 12 (1), 197 , 2012
    2012
    Citations: 97
  • Increased risk of second lung cancer in Hodgkin’s lymphoma survivors: a meta-analysis
    EM Ibrahim, GA Kazkaz, KM Abouelkhair, MM Al-Mansour, TM Al-Fayea, ...
    Lung 191 (1), 117-134 , 2013
    2013
    Citations: 58
  • Sunitinib adverse events in metastatic renal cell carcinoma: a meta-analysis
    EM Ibrahim, GA Kazkaz, KM Abouelkhair, AM Bayer, OA Elmasri
    International journal of clinical oncology 18 (6), 1060-1069 , 2013
    2013
    Citations: 48
  • Cetuximab-based therapy is effective in chemotherapy-naive patients with advanced and metastatic non-small-cell lung cancer: a meta-analysis of randomized controlled trials
    EM Ibrahim, KM Abouelkhair, OA Al-Masri, NC Chaudry, GA Kazkaz
    Lung 189 (3), 193-198 , 2011
    2011
    Citations: 45
  • Clinical outcome of panitumumab for metastatic colorectal cancer with wild-type KRAS status: a meta-analysis of randomized clinical trials
    EM Ibrahim, KM Abouelkhair
    Medical Oncology 28 (Suppl 1), 310-317 , 2011
    2011
    Citations: 23
  • Evaluation of inferior pedicle therapeutic mammoplasty as a primary procedure for upper quadrants early breast cancer
    A Denewer, W Elnahas, O Hussein, A Khater, W El-Sadda, K Abouelkher
    Adv Breast Cancer Res 2 (3), 86-90 , 2013
    2013
    Citations: 12
  • Prospective study of a molecular selection profile for RAS wild type colorectal cancer patients receiving irinotecan-cetuximab
    R Giampieri, A Mandolesi, KM Abouelkhair, C Loretelli, M Del Prete, ...
    Journal of translational medicine 13 (1), 140 , 2015
    2015
    Citations: 8
  • The additive role of 1H-magnetic resonance spectroscopic imaging to ensure pathological complete response after neoadjuvant chemotherapy in breast cancer patients
    D Bayoumi, M Zaky, D Ibrahim, A Abdallah, K Abouelkhair
    Polish journal of radiology 84, 570-580 , 2019
    2019
    Citations: 7
  • 190P The role of liver biopsy for unsettled HCC diagnosis: A single-center experience
    A El Sergany, W Elkashef, O Abdallah, O Elmetwally, RA Zayed, F Sabry, ...
    Annals of Oncology 35, S86 , 2024
    2024
    Citations: 1
  • MDCT evaluation of hepatic manifestations in Malignant hematological disorders
    A El-Badrawy, A Tawfik, G Saleh, M Abdel-Naby, H Ghazy, Z Emarah, ...
    CARDIOVASCULAR DISORDER AND MEDICINE Учредители: Science Repository OU, 1-6 , 2020
    2020
    Citations: 1
  • A Randomized, Double-Blind, Placebo Controlled Trial of Omeprazole as A Promising Drug for Protection Against Chemo Induced Neuropathy
    AKM Sadek AM, Hegazy SK, Hamada ZM
    Int J Drug Deliv Technol 16 (1s), 862-873 , 2026
    2026
  • Impact of consolidation chemotherapy after concurrent chemoradiation in locally advanced cervical cancer—a randomized controlled trial
    H Elghamery, GE Eladawei, H Wahba, R Hemida, KM Abouelkhair
    Oncology in Clinical Practice 22 , 2026
    2026
  • Association of PD-L1 expression with adverse pathological features in adult diffuse astrocytoma
    RK Elsaid, MM Abuhashim, SA Ashamallah, KM Abouelkhair, MM Zaki
    Egyptian Journal of Basic and Applied Sciences 12 (1), 526-541 , 2025
    2025
  • 633ep- Palbociclib + ET in Premenopausal women versus Combined Chemotherapy with HR+/Her2- Breast Cancer with Visceral Metastases
    MD Abdallah Ahmad Khalil, Khaled Abouelkhair, Mona Foda
    ESMO breast , 2025
    2025
  • Palbociclib plus endocrine therapy in Premenopausal women in HR+/Her2-Breast Cancer with Visceral Metastases versus Combined Chemotherapy
    MD Abdallah Ahmad Khalil, Khaled Abouelkhair, Mona Foda
    Journal of Carcinogenesis 24 (3), 635-642 , 2025
    2025
  • Treatment Outcome and Prognostic factors of Glioblastoma Multiforme
    AMF Ahmed EMA, Abdalla EA, Abouelkhair KM
    SECI Oncology 4, 344-352 , 2024
    2024
  • Science Repository
    A El-Badrawy, A Tawfik, G Saleh, M Abdel-Naby, H Ghazy, Z Emarah, ...
    2020
  • Molecular selection for colorectal cancer (CRC) patients receiving cetuximab: Final results of a prospective study.
    M Scartozzi, R Giampieri, M Del Prete, A Mandolesi, L Faloppi, ...
    Journal of Clinical Oncology 33 (3_suppl), 596-596 , 2015
    2015
  • Evaluation of the inferior pedicle therapeutic mammoplasty as a primary procedure for upper quadrant breast cancer
    A Denewer, W Elsoudi, O Hussein, A Khater, W El-sadda, K Abouelkher
    EUROPEAN JOURNAL OF CANCER 49, S464-S464 , 2013
    2013
  • Molecular biomarkers for a prognostic stratification of K-RAS wild type colorectal cancer patients receiving irinotecan-cetuximab: Preliminary results of a prospective study
    M Scartozzi, R Giampieri, A Mandolesi, KM Abouelkhair, C Loretelli, ...
    EUROPEAN JOURNAL OF CANCER 49, S562-S562 , 2013
    2013